ArticleIndian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine
Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing.
Article in Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As per World Health Organization (WHO), more than 350,000 lives were lost due to cervical cancer in 2022 and around 90% of which were from low- and middle-income countries (LMICs). This shows inequities among accessibility of cervical cancer screening in LMICs. In cervical cancer elimination strategy, WHO has recommended to use high performance test such as human papilloma virus (HPV) DNA test to do cervical cancer screening. Materials and Methods: A cross-sectional study was planned to document the prevalence of high-risk HPV (hrHPV) infection among females undergoing cervical cancer screening. A total of 367 cervical samples were collected at the Gujarat Cancer and Research Institute and community outreach areas of Rajpipla and Dholka talukas of Gujarat State which were tested for hrHPV. Results: Out of 367 samples, 204 samples were collected at cancer hospital and remaining samples were collected from camps. In this study, 31 samples (8.44%) were positive for hrHPV. High parity, early marriage, and irregular menstrual history have shown a significant association for hrHPV infections. Conclusion: Utilization of the HPV DNA test can be scaled up by considering it as the routine screening test which will help us to identify more females with HPV infection and eventually cervical cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.